Literature DB >> 7078327

Lymphoepithelioma of the nasopharynx.

E L Applebaum, P Mantravadi, R Haas.   

Abstract

There is uncertainty as to whether the clinical behavior of nasopharyngeal lymphoepithelioma differs from that of squamous cell carcinoma of the nasopharynx. To determine if significant differences existed, we have studied 39 patients with nasopharyngeal lymphoepithelioma and compared their data with 50 nasopharyngeal squamous cell carcinoma patients. In contrast to squamous cell carcinoma, lymphoepithelioma occurred at a younger age, presented as smaller primary tumors, and manifested more extensive cervical lymph node involvement. When analyzed by T stage, N stage, or overall stage groups, the 5-year actuarial survivals were better in the lymphoepithelioa patients. Late tumor recurrences (beyond 4 years) were seen in the lymphoepithelioma patients, whereas all of the recurrences in the squamous cell carcinoma group occurred within 4 years. Tumor recurrences were more common in the cervical lymph nodes in the lymphoepithelioma group and in the primary site of the squamous cell carcinoma group.

Entities:  

Mesh:

Year:  1982        PMID: 7078327     DOI: 10.1288/00005537-198205000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

Review 1.  Primary lymphoepithelioma-like hepatocellular carcinoma: report of a locally advanced case and review of literature.

Authors:  Song-Lin An; Li-Guo Liu; Yi-Ling Zheng; Wei-Qi Rong; Fan Wu; Li-Ming Wang; Li Feng; Fa-Qiang Liu; Fei Tian; Jian-Xiong Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Lymphoepithelioma-like intrahepatic cholangiocarcinoma with Epstein-Barr virus infection: report of a rare case.

Authors:  Yuan Ding; Zhongquan Sun; Wanlu You; Sitong Zhang; Chengdong Chang; Sheng Yan; Weilin Wang
Journal:  Ann Transl Med       Date:  2019-09

3.  Lymphoepithelioma‑Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report.

Authors:  Xiaolin Guo; Pujun Gao; Xu Li; Huifan Ji; Dezhi Zhang; Meishan Jin
Journal:  Cancer Manag Res       Date:  2022-07-04       Impact factor: 3.602

Review 4.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Clinical features of nasopharyngeal carcinoma in Jamaica.

Authors:  Susan A Douglas; N Nelson; H Ashman; Hal Shaw; J Kevin Fortson; Vijaykumar G Patel; Freda D McCarter
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

6.  Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies.

Authors:  S R Shi; M L Goodman; A K Bhan; B Z Pilch; L B Chen; T T Sun
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  High PD-L1 level of advanced hepatic lymphoepithelioma-like carcinoma response favorably to lenvatinib plus toripalimab.

Authors:  Yueting Zhu; Zhuyi Dang; Hang Xu; Yunlong Yuan; Ye Chen; Zhiping Li
Journal:  Cancer Sci       Date:  2022-03-24       Impact factor: 6.518

Review 8.  Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature.

Authors:  Jun-Ke Wang; Yan-Wen Jin; Hai-Jie Hu; Parbatraj Regmi; Wen-Jie Ma; Qin Yang; Fei Liu; Cong-Dun Ran; Fei Su; Er-Liang Zheng; Fu-Yu Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report.

Authors:  En-Jie Shih; Ivy Yenwen Chau; Yi-Chen Yeh; Gar-Yang Chau
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma.

Authors:  Zhuochen Cai; Jiali Jiang; Laiji Huang; Yawei Yuan; Ronghui Zheng; Jiangyu Zhang; Wenze Qiu
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.